本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

康乃德生物医药

0.7450
+0.00580.78%
盘后0.7103-0.0347-4.66%19:42 EDT
成交量:9.64万
成交额:7.20万
市值:4,123.52万
市盈率:-2.63
高:0.8039
开:0.8039
低:0.7072
收:0.7392
数据加载中...
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/24

SEC问询函

Form CORRESP - Correspondence
2023/04/11

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/07/01

SEC问询函

CORRESP [Cover] - Correspondence
2022/07/01

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/06/17

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/20

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership